Is Office-based Management of Intermediate-risk Low-grade Non-muscle-invasive Bladder Cancer Ready For Prime Time? Taylor J, Lotan Y. Eur Urol 2022 Sep 21. pii: S0302-2838(22)02629.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Taylor J, Lotan Y. Is Office-based Management of Intermediate-risk Low-grade Non-muscle-invasive Bladder Cancer Ready For Prime Time? Eur Urol 2022 Sep 21. pii: S0302-2838(22)02629.
PMID: 36153249